Member Info for Moorscloud

SMJ - seems Poly have indeed taken this approach to dividends. I did think though I'd heard that they were going to make some sort of statement about them in December presumably at this GM but presumably mistaken. Or have I missed something..?

Thank you Haywain - you have driven a cartload of golden sunshine into a miserably wet and grey Yorkshire weekend!

Most impressive / encouraging Haywain: begs a few questions.

Do Hemo's patents in this field mean that no-one else is developing or able to develop a similar wide-ranging platform?

Do any/many/most/all of these have existing treatments already?

In what ways is Hemo's CBR platform a better solution?

Is it any easier to develop any particular one of these in this list?

Are any of these more likely to be successful than others?

If it works for this list and the cancer application you mentioned as well, was Vlad's Microsoft comment actually a little modest..?

Thanks J-A-B

Good evening all. Is there meant to be news about dividend plans tomorrow?

Tilly - don't get it, can you please explain why there have been so many sells this morning after such a positive rns.

Chique, my apologies I forgot to mention you. I see from your past posts that many other Poly holders moved on to post instead on telegram as perhaps you do too. How is that done? With thanks.

Thanks for (re)posting this HH. Is it known how many other pre-clinical companies Prevail is currently working with or indeed roughly how many they have chosen NOT to work with?

Obviously if/WHEN Hemo gets IND approval, the credibility and confidence in the company will grow as well as the sp. Scientifically is there enough connection between the 3 treatments to mean also that this success will increase the chances of success of the others?

Fully understood and much appreciated, JHFH / HT many thanks.

Thanks in part to the excellent posts on this board detailing all the reasons to be cheerful, I have finally felt confident enough to discuss the current position (if not the precise size of my investment...) with my wife. Amongst many others, she asked a couple of wise and pertinent questions which I didn't feel I could answer well enough. 1) If Hemo is not actually going to produce and sell these amazing products itself, how is the company going to make money? 2) Is there ever a possibility that shareholders will receive dividends from Hemo so that we do not have (as we do at the moment) to sell our shares to get any rewards from our holdings? Thanks for all assistance!

Hello to JohnNth / smorrisjones / Dingo1 / E.Penfold / Just-Another-Bot / alter-ego and all those holders interested in discussing Polymetal. Really hoping you're still out there...

So your excellent side-note for clarity JHFH, is pretty much a silver lining then :)

Funny thought that, but for the lentivirus splicing issue, we would be clinical now. But would we have Prevail onboard so positively if that had happened so maybe there are some ways in which the postponement will prove to have been a good thing..?

Exciting enough times for us ordinary shareholders: can't even imagine what Vlad and his team must be feeling.

Interesting thread, thanks RB / JHFH. When you say "I suspect we will be taken over", I wonder at what stage/phase this would be most likely and would it have to be the whole company or just the individual treatments.

9.38 198,831 also a buy...

Good point 1902! That is surely too important a difference to be a mistake.

Just wondering (hoping) if any other posts also worked out how much 36,888 seconds is in hours...

Thinking about your clinical steps post HH, it can't be common for a small pharma to have 3 irons in the fire. Sorry for my ignorance but are they linked and is there a reason why Hemo have developed CAR-T first especially as CBX seems to be even more of a game-changer>